Antiarrhythmic Drug Use in Patients <65 Years of Age With Atrial Fibrillation and Without Structural Heart Disease

Little is known in clinical practice about antiarrhythmic drug (AAD) use in atrial fibrillation (AF) patients (particularly younger ones) that do not have structural heart disease. Using the MarketScan(®) database, we identified patients <65 years of age without known coronary artery disease or h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiol
Autors principals: Allen LaPointe, Nancy M., Dai, Dadi, Thomas, Laine, Piccini, Jonathan P., Peterson, Eric D., Al-Khatib, Sana M.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293335/
https://ncbi.nlm.nih.gov/pubmed/25491240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2014.11.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars